Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03527446
Other study ID # UNewBrunswick
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 3, 2018
Est. completion date February 28, 2020

Study information

Verified date March 2020
Source University of New Brunswick
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Regular exercise is a cornerstone in the prevention and the management of cardio-metabolic risk factors. Some of the beneficial effect of exercise training occurs through metabolic flexibility' enhancement. Metabolic flexibility is the ability to respond or adapt to conditional changes in metabolic demand, and previous literature has shown that individuals living with obesity have an impaired metabolic flexibility compared to lean individuals. However, there is a lack of empirical evidence on the impact of sprint interval training on metabolic flexibility and whether this translates into clinically meaningful outcomes.

This study will evaluate the impact of 4-week sprint interval training in normal weight individuals as well as individuals living with obesity on acute and chronic metabolic flexibility, irisin secretion and insulin sensitivity.


Recruitment information / eligibility

Status Completed
Enrollment 34
Est. completion date February 28, 2020
Est. primary completion date February 28, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 19 Years to 60 Years
Eligibility Inclusion Criteria:

- Adults (Ages 19-60)

- Physically inactive for individuals living with obesity (not meeting Canadian Physical Activity Guidelines)

- Normal Weight (BMI = 18.5 < 25.0 km/m2)

- Obesity (BMI = 30.0 km/m2)

Exclusion Criteria:

- Individuals with Type 2 Diabetes.

- Individuals with impaired glucose tolerance.

- Individuals living with obesity that partake in regular exercise training / meet the Canadian Physical Activity Guidelines.

- Individuals with a condition or injury that may impact the ability to perform exercise or may be worsened by exercise.

- Individuals currently being treated with corticosteroids or atypical antipsychotics, as these agents significantly influence carbohydrate metabolism.

- have experienced >10% weight loss or enrolled in weight loss program within six months of enrolment.

- require use of medication(s) known to affect insulin sensitivity or secretion within the last 30 days.

- Medication(s) known to cause weight gain.

- weight loss medication(s).

Study Design


Intervention

Behavioral:
Sprint Interval Training
The 4-week sprint interval intervention will consist of a work-rest ratio of four 30-s intervals of exercise at maximal capacity and 4-min of passive recovery at 50% of maximal capacity between intervals. There will be three sessions per week.

Locations

Country Name City State
Canada University of New Brunswick - Kinesiology Fredericton New Brunswick

Sponsors (1)

Lead Sponsor Collaborator
University of New Brunswick

Country where clinical trial is conducted

Canada, 

References & Publications (1)

Muoio DM. Metabolic inflexibility: when mitochondrial indecision leads to metabolic gridlock. Cell. 2014 Dec 4;159(6):1253-62. doi: 10.1016/j.cell.2014.11.034. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Metabolic Flexibility Chronic and acute metabolic flexibility will be quantified from the respiratory quotient (RQ) at rest and from the respiratory exchange ratio (RER) during a 4-6 minutes steady rate exercise bout. Baseline and post-intervention (4 weeks)
Primary Change in Insulin Sensitivity Insulin sensitivity will be measure with the Matsuda Index Baseline and post-intervention (4 weeks)
Secondary Change in Irisin This hormone will be quantified in the plasma during one acute session of exercise. Baseline and post-intervention (4 weeks)
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2